This 100% online Postgraduate diploma will provide you with the most optimal strategies for the management of antimicrobial therapies. You will reduce the risk of nosocomial infections associated with resistant pathogens!"

Bacterial resistance is one of the most complex problems in healthcare, as it can lead to a significant increase in mortality. In this context, nurses play a key role in the implementation of clinical management strategies to address infections caused by Multidrug-Resistant Bacteria. In order to optimize their patient outcomes, these professionals need to update their competencies on a regular basis. Only in this way can experts stay abreast of the latest resistant strains and the most effective treatment strategies, enabling them to provide higher quality care.  

In this scenario, TECHlaunches an innovative Postgraduate diploma in Clinical Management of Multidrug-Resistant Bacteria for Nursing. Designed by references in this field, the academic itinerary will delve into the risk factors for nosocomial infections. In this way, nurses will conduct more comprehensive surveillance for signs of infection and implement specific preventive measures as needed. At the same time, the syllabus will comprehensively address the epidemiology of infections caused by Gram-negative microorganisms. In addition, the program will provide graduates with the most sophisticated tools to estimate the risk of presence of these bacteria and offer the most effective treatments to ensure optimal patient recovery. The study plan will also investigate antibiotic resistance, enabling professionals to apply effective measures to control nosocomial infections.   

On the other hand, the program is based on a 100% online modality that allows nursing staff to plan their own study schedules. In line with this, TECHemploys its disruptive Relearning methodology, consisting of the reiteration of key concepts for an organic assimilation of the contents. Thanks to this, professionals will enjoy a progressive and natural updating. It should be noted that the only thing they will need to access the Virtual Campus is an electronic device with Internet access.

Delve into state-of-the-art quality indicators for infection prevention at the world's best digital university according to Forbes”

This Postgraduate diploma in Clinical Management of Multidrug-Resistant Bacteria for Nursing contains the most complete and up-to-date scientific program on the market. The most important features include:

• The development of case studies presented by experts in Microbiology, Medicine and Parasitology
• The graphic, schematic and eminently practical contents with which it is conceived gather scientific and practical information on those disciplines that are indispensable for professional practice 
• Practical exercises where the process of self-assessment can be used to improve learning 
• Its special emphasis on innovative methodologies  
• Theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments 
• Content that is accessible from any fixed or portable device with an Internet connection

You'll delve into how PEIA teams can improve antimicrobial use by implementing coordinated strategies” 

The program’s teaching staff includes professionals from the sector who contribute their work experience to this specializing program, as well as renowned specialists from leading societies and prestigious universities. 

The multimedia content, developed with the latest educational technology, will provide the professional with situated and contextual learning, i.e., a simulated environment that will provide immersive education programmed to learn in real situations. 

This program is designed around Problem-Based Learning, whereby the professional must try to solve the different professional practice situations that arise during the course. For this purpose, students will be assisted by an innovative interactive video system created by renowned and experienced experts. 

You will manage antibiotic therapy strategies for the treatment of Gram-negative bacteria and you will adequately evaluate the effects of the applied therapies”

TECH Relearning methodology will allow you to organize your own schedules and study time, so that you can combine your updating process with your professional work” 

With this Postgraduate diploma, nurses will have a deep understanding of the mechanisms of bacterial resistance and its relationship with the treatment of infections. The syllabus will analyze the main risk factors of nosocomial infections, enabling graduates to implement preventive measures to control them. Likewise, the syllabus will provide the most innovative prevention strategies according to the focus that causes them (among which Pneumonia, Bacteremia and urinary tract infections stand out). The program will also examine the pathogenesis of infections caused by Gram-negative microorganisms, addressing the most appropriate treatments for the recovery of patients.

You will master the most effective measures to prevent the spread of multidrug-resistant bacteria in clinical care settings” 

Module 1. Management of Patients with Multidrug-Resistant Bacterial Infections in Intensive Care Units (ICU) 

1.1. Colonization and Infection of Patients in ICUs

1.1.1. Types of ICUs
1.1.2. Epidemiology
1.1.3. Risk Factors Associated with Infection in ICUs

1.2. Impact of Nosocomial Infections in the Critically Ill Patient

1.2.1. Importance of Nosocomial Infections in ICUs
1.2.2. Risk Factors for Nosocomial Infections

1.2.2.1. Patient Factors
1.2.2.2. Factors of the ICU Environment
1.2.2.3. Factors Related to the Healthcare Personnel

1.2.3. Impact of Nosocomial Infections in Immunocompromised Patients
1.2.4. Impact on Length of Stay in the ICU

1.3. Pneumonia Associated with Mechanical Ventilation

1.3.1. Etiology
1.3.2. Diagnosis
1.3.3. Treatment

1.4. Urinary Tract Infections Associated with Catheters

1.4.1. Etiology
1.4.2. Diagnosis
1.4.3. Treatment

1.5. Primary Bacteremias and Catheter-Related Bacteremias

1.5.1. Etiology
1.5.2. Diagnosis
1.5.3. Treatment

1.6. Pseudomembranous Colitis

1.6.1. Etiology
1.6.2. Diagnosis
1.6.3. Treatment

1.7. Infections by Opportunistic Pathogens

1.7.1. Etiology
1.7.2. Diagnosis
1.7.3. Treatment

1.8. Appropriate Use of Antibiotics

1.8.1. Programs for the Optimization of Antibiotic use (PROA) in the ICU
1.8.2. Antibiotic Therapy Strategies for the Treatment of Gram-Negative Patients
1.8.3. Antibiotic Therapy Strategies for the Treatment of Gram-Positive Patients
1.8.4. Antibiotic Therapy Strategies for the Treatment of Co-Infections

1.9. Strategies for the Prevention of BMR Infections in the ICU

1.9.1. Hygiene Measures
1.9.2. Infection Control Measures
1.9.3. Protocols and Clinical Practice Guidelines
1.9.4. Education and Training of ICU Personnel
1.9.5. Participation of Patients and their Families

1.10. Infection Prevention Strategies in the ICU

1.10.1. Infection Prevention Strategies in the ICU According to the Focus

1.10.1.1. Pneumonia
1.10.1.2. Bacteremia
1.10.1.3. Urinary Infection

1.10.2. Evaluation and Quality Indicators in the Prevention of Infections
1.10.3. Evaluation and Continuous Improvement Tools
1.10.4. Successful Examples of Infection Prevention in ICUs 

Module 2. Multidrug-Resistant Gram Negative Bacteria

2.1. Infections Due to Gram-Negative Microorganisms

2.1.1. Epidemiology of Gram-Negative Microorganisms
2.1.2. Community and Nosocomial Infections by Gram-Negative Microorganisms
2.1.3. Relevance of Infections by Multidrug-Resistant Gram-Negative Microorganisms

2.2. Pathogenesis of Infections by Gram-Negative Microorganisms

2.2.1. Factors Related to Gram-Negative Microorganisms
2.2.2. Patient Factors in Gram-Negative Infections
2.2.3. Other Factors in Gram-Negative Infections

2.3. Clinical Evaluation of Patients with Multidrug-Resistant Gram-Negative Infections

2.3.1. Medical History
2.3.2. Clinical Evaluation of Patients
2.3.3. Other Data of Interest

2.4. Complementary Tests in Infections by Multidrug-Resistant Gram-Negative Microorganisms

2.4.1. Blood Tests
2.4.2. Imaging Tests
2.4.3. Microbiological Techniques

2.5. Estimation of Severity in Patients with Infections by Multidrug-Resistant Gram-Negative Microorganisms

2.5.1. Gram-Negative Multidrug-Resistant Microorganisms
2.5.2. Traditional Approach to Severity Estimation
2.5.3. Practical Conclusions

2.6. Risk of Acquiring Infections by Multidrug-Resistant Gram-Negative Microorganisms

2.6.1. Clinical Factors in the Acquisition of Infections by Multidrug-Resistant Gram-Negative Microorganisms
2.6.2. Other Factors in the Acquisition of Infections by Multidrug-Resistant Gram-Negative Microorganisms
2.6.3. Tools to Calculate the Risk of Presence of Multidrug-Resistant Gram-Negative Microorganisms

2.7. Empirical Treatment in the Suspicion of Infections by Multidrug-Resistant Gram-Negative Microorganisms

2.7.1. Microorganisms Involved According to Localization
2.7.2. Comprehensive Assessment of Patients with Suspected Infections by Multidrug-Resistant Gram-Negative Microorganisms
2.7.3. Selection of Empirical Antibiotic Treatment

2.8. Targeted Therapy in Infections by Multidrug-Resistant Gram-Negative Microorganisms

2.8.1. Adjustment of Antibiotic Therapy According to Microbiological Results
2.8.2. Follow-up of Multidrug-Resistant Gram-Negative Microorganism Infection
2.8.3. Most Relevant Side Effects of Antibiotherapy

2.9. Duration of Antibiotherapy in Infections by Multidrug-Resistant Gram-Negative Microorganisms

2.9.1. Estimation of the Duration of Antibiotic Treatment in Infections by Multidrug-Resistant Gram-Negative Microorganisms
2.9.2. Relevance of Focus Control in Infections by Multidrug-Resistant Gram-Negative Microorganisms
2.9.3. Special Considerations Related to Antibiotic Therapy in These Infections

2.10. PROA Teams in Infections Caused by Multidrug-Resistant Gram-Negative Microorganisms

2.10.1. PROA Teams: History
2.10.2. Impact of PROA Teams on the Correct Use of Antibiotic Treatments
2.10.3. Challenge of PROA Teams in the Treatment of Infections Caused by Multidrug-Resistant Gram-Negative Microorganisms

Module 3. Antibiotic Resistance in Streptococcus, Enterococcus and Staphylococcus 

3.1. Infections Due to Gram-Positive Bacteria

3.1.1. Natural Habitat of Gram-Positive Pathogens
3.1.2. Nosocomial Infections due to Gram-Positive Bacteria
3.1.3. Community-Acquired Infections by Gram-Positive Bacteria

3.2. In Vitro and in Vivo Systems for the Study of Resistance in Gram-Positive Bacteria

3.2.1. Biofilms
3.2.2. Cellular Models
3.2.3. Animal Models

3.3. Streptococcus Pneumoniae

3.3.1. Clinical Significance
3.3.2. Resistance Mechanisms
3.3.3. Biofilms
3.3.4. Treatment Options

3.4. Streptococcus Pyogenes

3.4.1. Clinical Significance
3.4.2. Resistance Mechanisms
3.4.3. Biofilms
3.4.4. Treatment Options

3.5. Streptococcus Agalactiae

3.5.1. Clinical Significance
3.5.2. Resistance Mechanisms
3.5.3. Biofilms
3.5.4. Treatment Options

3.6. Enterococcus Faecalis

3.6.1. Clinical Significance
3.6.2. Resistance Mechanisms
3.6.3. Biofilms
3.6.4. Treatment Options

3.7. Enterococcus Faecium

3.7.1. Clinical Significance
3.7.2. Resistance Mechanisms
3.7.3. Biofilms
3.7.4. Treatment Options

3.8. Staphylococcus Aureus

3.8.1. Clinical Significance
3.8.2. Resistance Mechanisms
3.8.3. Biofilms
3.8.4. Treatment Options

3.9. Mycobacterium Tuberculosis

3.9.1. Clinical Significance
3.9.2. Resistance Mechanisms
3.9.3. Treatment Options

3.10. Resistance in Other Gram-Positive Bacteria

3.10.1. Coagulase-Negative Staphylococcus
3.10.2. Clostridioides Difficile
3.10.3. Emerging Gram Positive Pathogens

A rigorous and scientifically focused syllabus that will take your nursing career to the next level.What are you waiting for to enroll?"